Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. - Wikidata - wikimedia - TriplyDB

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

http://www.wikidata.org/entity/Q42111937

about

Role of complement and NK cells in antibody mediated rejection Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality.Recent advances in renal transplantation: antibody-mediated rejection takes center stage Rational clinical trial design for antibody mediated renal allograft injury.Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates.Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy Banff 2011 Meeting report: new concepts in antibody-mediated rejection IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES.Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.Clinical role of the renal transplant biopsy.The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.Phenotypes of antibody-mediated rejection in organ transplants.Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation.The significance of histological diagnosis in renal allograft biopsies in 2014.The increasing clinical importance of alloantibodies in kidney transplantation.Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes.The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations.Current pathological perspectives on chronic rejection in renal allografts.Current status of pediatric renal transplant pathology.Postanastomotic transplant renal artery stenosis: association with de novo class II donor-specific antibodies.Clinical and pathological analyses of chronic vascular rejection after kidney transplantation.Renal allograft rejection: pieces of the puzzle.Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma.Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome.Histopathological and clinical findings in renal transplants with Banff type II and III acute cellular rejection without tubulointerstitial infiltrates.The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice.Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection.Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation.Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation.The Spectrum of Histopathological Changes in the Renal Allograft - a 12 Months Protocol Biopsy Study.

P2860

Q26864255-CB8DED8E-2AF9-4088-A3C6-71DCA07AFABF Q33871590-D1F6CFE3-663E-416A-B86D-F4B382562E5C Q35659332-F09C5FBB-0733-4545-88EB-2B3E2239F766 Q36173541-9FD282EF-685A-4CE3-B642-BA6F9F9494A4 Q36514884-752033D5-1B7D-46D5-9752-95999FFB4A88 Q37044541-B1FE65EC-BB85-48CA-AB4B-B901C930ABCB Q37058043-781C4BD3-A332-46F3-BA4F-FC1096726BC1 Q37563822-AAB3C9DB-DF3D-4E35-9213-AB56EAFA7DBA Q37660263-B18F8D93-41B5-4914-892C-5B04595F51F5 Q37974480-FC7D69C1-C3D1-46B3-B0AE-16FCEEEE98DD Q38003049-AB949C41-B3BA-4116-A363-5B5AA94E2D3A Q38005448-38F7FA51-6CAA-4434-9904-AEDCF38A7082 Q38116657-85699265-B731-441D-93A4-113EDA009B48 Q38154130-F731CFCE-9C85-4778-B0C8-0401D0791D0F Q38247690-D2ACCE8B-B04B-41E4-B16F-53164186664D Q38258153-8A10085A-7EAC-491E-9A54-3C25DD7243A2 Q38374793-6A9AC5BA-56FF-4CCE-94C0-011CF633BDFF Q38630386-C7794E52-AAA4-4BDE-9D6E-8122351FB273 Q38676925-736B2178-0A24-4635-9A3F-71DB4D44E72F Q38795065-B9D5E1B5-3CE2-4BD1-95A8-22DB44BD9283 Q38843499-9D5D25D6-F3EC-4570-BCEC-19C696182147 Q40159121-9EB36BCD-C904-44A5-9D1F-A20BFE29E8A4 Q40882057-314A15B5-7E41-498D-A48D-4DD45B76F56F Q42582852-F8CB1C7A-0736-49D6-A11B-E27027B8325F Q44911053-71EB6C79-0FC8-4682-BBBA-7AB465F0F807 Q46322442-97DF229D-B519-42E4-B682-1CB5C9DAF41D Q48901557-CBBF5D49-0F34-4DF6-8645-2426D1324D83 Q49521510-4B7B2333-53FB-4CDF-A3DA-F9C055F723F9 Q50910367-58FAF10F-000C-4365-B247-020180C296EA Q52881666-9DAE9914-89BA-4500-86EC-C17FC6DF09CF Q52889823-F2737B77-3013-4B57-82A9-DBE048F792DA Q53825191-CD4E0FC2-031A-4F79-BAE8-C7D5D05E46F0

P2860

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

http://www.wikidata.org/entity/Q42111937

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

@en

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

@nl

type

label

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

@en

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

@nl

prefLabel

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

@en

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

@nl

P1433

Q42111937-1E207A5A-89FD-4771-852F-E367B4445F59

P1476

Q42111937-92D64E0F-A092-4A83-AFEA-5E343D65C4DE

P2093

Q42111937-008B2183-D823-4643-A80E-A17AD97D189D

Q42111937-03218CDC-C0E8-4CFE-A05E-1A90A14F644A

Q42111937-590470BE-8E1B-4586-98BD-125AEFB7ED36

Q42111937-62EE4C84-0D0F-4D7F-90C5-604FBCEDC2DB

Q42111937-6A4D6258-EA4A-4425-AB99-E2458EBFC0A1

Q42111937-7BC9ED71-56F7-467E-9FCA-AD5A72BF85AD

Q42111937-95C5E7F3-FCEA-4448-88B0-099486BB7A43

Q42111937-B46AC656-77C0-4ABA-85D1-AC6DAB1D5107

Q42111937-CB8F07B6-7CBF-4782-9959-2D18D51C16CC

P2860

Q42111937-14AEC791-DF46-4ADA-8029-F020D8CF94F3

Q42111937-1C2F38B4-6D35-4F5B-A94C-C3AA17F8A583

Q42111937-2BC8E51B-3388-4DE8-9B54-0D01D88168F2

Q42111937-43E985A3-4C16-475B-B97D-BEDCF360A28E

Q42111937-507B66E2-B1AD-4825-9B80-0F8300DBB220

Q42111937-826026D6-3C6B-470F-97E9-5250EC2E32E1

Q42111937-8A336BCD-237D-41AD-B62C-2D4755DD3F0A

Q42111937-948AB6A5-FD7C-494E-B5D4-7754BD865FFE

Q42111937-BDE3BCC9-D7E7-4D0B-94A8-1426A9D98CAB

Q42111937-C52D5615-1EC1-4DA0-82B0-6294B73DE4E8

P304

Q42111937-9797899D-29C3-4607-8681-631C18D2A052

P31

Q42111937-8D148D19-F03B-43F2-B7B7-81286B1A604A

P356

Q42111937-2C44E0FD-E108-47A1-B94F-7B2C42F3C415

P433

Q42111937-69A12419-2224-4D77-ADDD-83E4F51999A6

P478

Q42111937-7E994795-F24C-4645-BEE2-10A6FE46998E

P50

Q42111937-43104E33-25E0-469F-97EB-FD8E0781F3CE

Q42111937-4C37E74E-3200-4589-AF24-EB2C7B7140B2

P577

Q42111937-178538A4-C008-447F-BD30-7C49C9479FF9

P5875

Q42111937-A5A5E6D8-923F-46DC-9C1C-0EF32E9A4CD6

P698

Q42111937-BC9DF5C4-80C4-48FE-BA4A-B7A6D22BE475

P921

Q42111937-EEB21A1A-18C4-47EC-8292-1D805FD33E8B

P932

Q42111937-B0331D3F-AC11-435C-8141-FB87AE3E1C82

P356

P1433

Journal of the American Society of Nephrology

P1476

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation

@en

P2093

Alexandre Loupy

http://www.w3.org/2001/XMLSchema#string

Caroline Suberbielle

http://www.w3.org/2001/XMLSchema#string

Christophe Legendre

http://www.w3.org/2001/XMLSchema#string

Dany Anglicheau

http://www.w3.org/2001/XMLSchema#string

Dominique Nochy

http://www.w3.org/2001/XMLSchema#string

Gary S Hill

http://www.w3.org/2001/XMLSchema#string

J P Duong van Huyen

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Empana

http://www.w3.org/2001/XMLSchema#string

Patrick Bruneval

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis.

Kidney transplantation: mechanisms of rejection and acceptance.

Relevance of MICA and other non-HLA antibodies in clinical transplantation.

The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells.

Accelerated arteriosclerosis: a form of transplant arteriopathy.

Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study.

Banff 07 classification of renal allograft pathology: updates and future directions.

Clinicopathological analysis of acute vascular rejection cases after renal transplantation.

Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability.

Anti-HLA class I antibodies transduce signals in endothelial cells resulting in FGF receptor translocation, down-regulation of ICAM-1 and cell proliferation.

P304

975-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010070777

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51051920

http://www.w3.org/2001/XMLSchema#string

P698

21493773

http://www.w3.org/2001/XMLSchema#string

P921

P932

3083319

http://www.w3.org/2001/XMLSchema#string